Abstract
The article summarizes the literature data on vertebral artery syndrome, its clinical manifestations, etiology and pathogenesis. Based on their own results, the possibilities of pathogenetic therapy of the disease with nicergoline are considered. 22 patients aged 21-71 years were treated with nicergoline (half of them were treated in a hospital, the rest on an outpatient basis). The duration of treatment ranged from 2 to 6 months. The positive effect of nicergoline on the most common clinical symptoms, such as headache, dizziness, as well as a persistent or sharp (crisis) increase in blood pressure, has been established. Long-term therapy with nicergoline showed a significant improvement in the quality of life of patients on the SF-36 scale. The effectiveness of nicergoline therapy has been established for any variant of the development of vertebral artery syndrome, i.e. regardless of the cause of this condition.